Open Access

Metabonomic signature analysis of cervical carcinoma and precancerous lesions in women by 1H NMR spectroscopy

  • Authors:
    • Ayshamgul Hasim
    • Mayinuer Ali
    • Batur Mamtimin
    • Jun‑Qi  Ma
    • Qiao-Zhi Li
    • Abulizi Abudula
  • View Affiliations

  • Published online on: March 12, 2012     https://doi.org/10.3892/etm.2012.509
  • Pages: 945-951
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

1H nuclear magnetic resonance (NMR)-based metabonomics has been used to characterize the metabolic profiles of cervical intraepithelial neoplasia (CIN) and cervical squamous cell carcinoma (CSCC). Principal component analysis (PCA) and orthogonal partial least-squares discriminant analysis (OPLS-DA) were used to model the systematic variation related to patients with CIN or CSCC with healthy controls. Potential metabolic biomarkers were identified using database comparisons, and the one‑way analysis of variance (ANOVA) test was used to examine the significance of the metabolites. Compared with plasma obtained from the healthy controls, plasma from patients with CIN had higher levels of very-low density lipoprotein (VLDL), acetone, unsaturated lipid and carnitine, together with lower levels of creatine, lactate, isoleucine, leucine, valine, alanine, glutamine, histidine, glycine, acetylcysteine, myo-inositol, choline and glycoprotein. Plasma from patients with CSCC had higher levels of acetate and formate, together with lower levels of creatine, lactate, isoleucine, leucine, valine, alanine, glutamine, histidine and tyrosine compared with the plasma of the healthy controls. In addition, compared with the plasma of patients with CIN, the plasma of CSCC patients had higher levels of acetate, formate, lactate, isoleucine, leucine, valine, alanine, glutamine, histidine, tyrosine, acetylcysteine, myo‑inositol, glycoprotein, α-glucose and β-glucose, together with lower levels of acetone, unsaturated lipid and carnitine. Moreover, the profiles showed high feasibility and specificity by statistical analysis with OPLS-DA compared to the Thinprep cytology test (TCT) by setting the histopathological outcome as standard. The metabolic profile obtained for cervical cancer is significant, even for the precancerous disease. This suggests a systemic metabolic response to cancer, which may be used to identify potential early diagnostic biomarkers of the cancer and to establish clinical diagnostic methods.
View Figures
View References

Related Articles

Journal Cover

June 2012
Volume 3 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Hasim A, Ali M, Mamtimin B, Ma JQ, Li Q and Abudula A: Metabonomic signature analysis of cervical carcinoma and precancerous lesions in women by 1H NMR spectroscopy. Exp Ther Med 3: 945-951, 2012
APA
Hasim, A., Ali, M., Mamtimin, B., Ma, J., Li, Q., & Abudula, A. (2012). Metabonomic signature analysis of cervical carcinoma and precancerous lesions in women by 1H NMR spectroscopy. Experimental and Therapeutic Medicine, 3, 945-951. https://doi.org/10.3892/etm.2012.509
MLA
Hasim, A., Ali, M., Mamtimin, B., Ma, J., Li, Q., Abudula, A."Metabonomic signature analysis of cervical carcinoma and precancerous lesions in women by 1H NMR spectroscopy". Experimental and Therapeutic Medicine 3.6 (2012): 945-951.
Chicago
Hasim, A., Ali, M., Mamtimin, B., Ma, J., Li, Q., Abudula, A."Metabonomic signature analysis of cervical carcinoma and precancerous lesions in women by 1H NMR spectroscopy". Experimental and Therapeutic Medicine 3, no. 6 (2012): 945-951. https://doi.org/10.3892/etm.2012.509